secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2023-01-12T23:59:59+00:00
Accession:  0001818331-23-000011
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx presents at J.P. Morgan Healthcare Conference; full presentation details not available in filing
--------------------------------------------------------------------------------

- Investor presentation furnished as Exhibit 99.1 for the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023.
- Tagline: 'One Test: Miss Less. Discover More.' CEO Katherine Stueland presented.
- No specific financial guidance or operational metrics were extractable from the truncated filing exhibit.
- The presentation may contain material information, but the full content was not provided in the current filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000011/0001818331-23-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000011/smfr-20230112.htm
  HTML page:      https://secwatch.observer/filing/0001818331-23-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer